The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,329 records6 sources
Showing 193–216 of 11,329
ArticleAyahuasca

N,N-Dimethyltryptamine and harmine formulation alters transient EEG topography sequences near the peak of the psychedelic state.

Niedernhuber M, Suay D, Lenggenhager B +4

Europe PMC2026
ArticlePsilocybin

Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice.

Hogg DE, Romanos J, Albiez J +8

Europe PMC2026
ArticleKetamine

Patient Factors Associated With Subanesthetic-Dose Ketamine Infusion in the Postanesthesia Care Unit.

Thomas A, Bazinski M, Michaels B +4

Europe PMC2026
ArticleKetamine

Reply to 'Methodological concerns and interpretative limitations of assessing subjective effects of ketamine'.

Dahan JDC, Dadiomov D, Bostoen T +1

Europe PMC2026
ArticleKetamine

Matters arising: Methodological concerns and interpretative limitations of assessing subjective effects of ketamine.

Janavičius R

Europe PMC2026
ArticleKetamine

Esketamine For the Treatment of Depression in a Patient With Multiple Sclerosis.

Mathews M, Aickareth G, Abraham A +5

Europe PMC2026
ArticleKetamine

S-propargyl-L-cysteine attenuates ketamine induced schizophrenia-like behaviors and neuroinflammation in mice via inhibition of NF-κB/NLRP3 inflammasome-mediated pyroptosis.

Wang H, Huang Y, Hu Q +14

Europe PMC2026
PreregistrationKetamine

Ketamine for TRD: Do the Guidelines Follow the Science? A Systematized Review

OSF2026
ArticleKetamine

Ketamine versus Etomidate as an induction agent for tracheal intubation: An updated meta-analysis of randomized clinical trials.

Elbahloul MA, Gamal A, Samir AA +2

Europe PMC2026
ArticlePsilocybin

Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study.

Eigenbrodt AK, Laigaard PP, Hassani M +5

Europe PMC2026
ArticleKetamine

An Overview of Depression Pathogenesis: Prevailing Hypotheses and Associated Neurobiological Underpinnings Primarily Evidenced by Rodent Studies.

Zhang B, Li C

Europe PMC2026
ArticleKetamine

Rapid antidepressant-like effects of Chaihu Shugan San in female restraint-stressed mice: involvement of hippocampal TC2N and ERβ-eNOS-CaMKII-BDNF signaling.

Wu L, Cheng W, Xiang H +7

Europe PMC2026
ArticlePsychedelics

Psychedelic-assisted therapy research for people with HIV.

Vergel N, Saberi P

Europe PMC2026
ArticleMDMA

Development and Validation of an LC-MS/MS Method for the Detection of Substituted Phenethylamines and Phenidates Designated as Temporary Narcotics in Urine.

Jeong S, Kim Y, Kang S +3

Europe PMC2026
Trial

Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery

ClinicalTrials.gov2026
DatasetPsilocybin

AutoPsy - Autobiographical Memories and Psychedelics

Kangaslampi, Samuli, Kuypers, Kim P. C.

Zenodo2026
ArticleKetamine

A longitudinal analysis of the clinical practice of ketamine assisted psychotherapy with adolescents and young adults.

Wolfson P, Carroll C

Europe PMC2026
ArticlePsilocybin

Prior trauma shapes the effects of psilocybin on stress sensitization in mice.

Ottofaro SR, Maltman JL, González-Maeso J

Europe PMC2026
ArticlePsilocybin

A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults.

Levy-Cooperman N, Sellers E, Glue P +5

Europe PMC2026
ArticlePsilocybin

An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.

Downey AE, Szigeti B, Bradley ER +11

Europe PMC2026
PreprintPsilocybin

Curious about Psilocybin? Prevalence and correlates of interest among adults with chronic pain.

Crawford CML, Walsh Z, Louw WF +1

Europe PMC2026
ArticleKetamine

Implementation and Preliminary Evaluation of an Intravenous Ketamine Protocol for Psychiatric Conditions in Medical and Surgical Units: A One-Year Pilot Study.

Hu B, Ortiz-Cruz A, Sachidanandan R +2

Europe PMC2026
ArticleKetamine

Modulation of GABA and glutamate by ketamine in depression: A systematic review and meta-analysis of magnetic resonance spectroscopy studies.

Singh B, Ali HM, Miola A +8

Europe PMC2026
ArticleMDMA

Methylenedioxymethamphetamine (MDMA)-related fatal poisoning in Australia, 2016 to 2025: Trends, characteristics and toxicology.

Darke S, Duflou J, Chrzanowska A +3

Europe PMC2026